Author:
Sharon Shainy Mathews Pharm D, MPH- University of Sheffield, UK
Reviewed by:
Erin Page MSc in Precision Medicine and Pharmacological Innovation, University of Glasgow
Nour Asaad MSc Applied Biomolecular Technology, The University of Nottingham

Introduction

The liver is the largest gland in the human body and is responsible for essential processes like metabolism, detoxification, and nutrient storage. Liver cancer is a serious condition that impacts the liver. Hepatocellular carcinoma (HCC), the most common type of liver cancer, is often caused by long-lasting liver diseases. Although fatty liver disease, alcoholism, and hepatitis infections are well-known causes of liver cancer, the importance of sleep for liver health is also becoming more widely recognised.

The foundation of both mental and physical health is sleep. It enables the body to improve the immune system, control hormones, and heal tissues. Inadequate or poor sleep can result in hormonal imbalances, insulin resistance, and systemic inflammation, all of which harm liver function. Furthermore, sleep is essential for controlling circadian rhythms, which impact liver metabolism. Over time, liver function may be hampered by disturbances in these cycles. The relationship between sleep and liver cancer is examined in this article, with a focus on how sleep disruptions may affect the development and risk of liver cancer.1,2,3

Liver cancer and sleep: understanding the connection

Liver cancer is a dangerous disease that starts in the liver. Hepatocellular carcinoma (HCC), the most prevalent kind of liver cancer, usually appears in people who have severe liver conditions such as cirrhosis or hepatitis. Although they are less frequent, other forms include angiosarcoma and intrahepatic cholangiocarcinoma (bile duct cancer).4,5

Symptoms

In its early stages, liver cancer symptoms are frequently undiscovered. Nevertheless, as the disease advances, people may experience several symptoms:

Other symptoms may also present, such as:

Managment

Depending on the extent of the cancer, liver cancer can be treated in different ways, which includes:6

Palliative care for advanced cases is centred on enhancing the quality of life and symptom alleviation.7

The connection

Sleep is essential for general health and has a big effect on liver function. HCC risk can be raised by poor sleep quality, which can worsen liver damage-causing factors such as insulin resistance and systemic inflammation. Additionally, sleep disorders impair immune surveillance by decreasing the activity of natural killer (NK) cells, which are crucial for detecting and eliminating abnormal cells. 

By addressing poor sleep, through strategies like stress management or regular sleep regimens, the risk of liver problems as a consequence can be reduced. This could be crucial for improving outcomes and preventing liver cancer where possible.8,9,10

Sleep problems in liver cancer patients

People with liver cancer frequently experience sleep disruptions, which can worsen the disease course and have a substantial negative influence on their quality of life. Insomnia, restless legs syndrome (RLS), excessive daytime sleepiness (EDS), and overnight awakenings are common sleep issues. Research indicates that more than half of the people with liver cancer have poor sleep quality. 

Fatigue brought on by the illness or its treatments, disturbing sleep at night, are common causes of EDS. Sleep cycles are further disturbed by nighttime awakenings brought on by pain, discomfort, or frequent urination, and RLS is commonly seen in people with chronic liver diseases.11,12

These sleep problems are caused by several circumstances. For example, the psychological effects of fear or sadness following a cancer diagnosis, side effects of treatments like chemotherapy or targeted therapies, and pain or discomfort from abdominal swelling (ascites). 

Liver disease is a major factor in circadian rhythm disruption. The liver regulates the metabolism of melatonin, and if the liver is not functioning properly, it can result in slower melatonin clearance, disrupting biological clocks and leading to abnormal sleep patterns. People diagnosed with liver cancer might experience improved sleep and overall well-being if issues are managed through pain relief, psychological assistance, and medications designed to help restore the circadian rhythm.13,14,15

Biological connection between liver cancer and sleep

Insufficient sleep might worsen factors that elevate the likelihood of liver cancer. Chronic sleep deprivation has been associated with heightened oxidative stress and inflammation, both of which are significant contributors to liver damage. Additionally, it impairs insulin sensitivity and glucose metabolism, accelerating the development of non-alcoholic fatty liver disease (NAFLD)

Sleep problems are common in people with chronic liver illness because of decreased melatonin metabolism and thermoregulatory dysfunction. These disruptions have the potential to deteriorate immunological and metabolic health, resulting in the proliferation of cancer cells due to this compromised response.2,9,15

Impact of poor sleep on liver cancer outcomes

Lack of sleep can diminish the effectiveness of liver cancer therapies, including immunotherapy, targeted therapy, and chemotherapy. Sleep deprivation disrupts the balance of cortisol and melatonin, which are crucial hormones for regulating the immune system and repairing cells. 

The antioxidant qualities of melatonin guard against the cell damage brought on by cancer treatments, and cortisol aids in immune response modulation. These hormonal functions can be hampered by irregular sleep patterns, which lower the body's capacity to react to therapy.3,10,17,18

People with liver cancer have a much lower quality of life when they do not get enough sleep. Common problems that result in exhaustion and diminished physical functioning include insomnia, EDS, and nightly awakenings. In addition to making it more difficult for patients to manage the difficulties of their disease, sleep interruptions can worsen mental anguish and pain perception. While sleep aids and various interventions may provide some comfort, their impact on individuals' overall quality of life remains uncertain. Effectively addressing sleep problems could reduce these pressures and improve individuals' overall well-being.2,9

Management of sleep issues in liver cancer

Lack of sleep impairs the quality of life, weakens the immune system, and decreases the effectiveness of treatment. Improving outcomes for these individuals requires effective management techniques that include behavioural, supportive, and medicinal approaches.

Medical intervention

Pain management 

Ascites (or fluid accumulation) and stomach pain are common side effects of advanced liver cancer that interfere with sleep. Discomfort can be reduced by analgesics and ascites-reducing treatments like paracentesis or diuretics. For example, lactulose (a laxative) has been found to positively influence sleep quality when used to treat individuals with hepatic encephalopathy (a potential side effect of liver cancer).19,20

Changing the timing of medication

Chronotherapy, which synchronises the administration of medications with circadian cycles, may improve the effectiveness of treatment. Scheduling chemotherapy or immunotherapy to align with times of heightened immune activity, often occurring during the day, could improve tumour targeting and minimise side effects. Stabilising sleep-wake cycles is also aided by avoiding stimulant drugs in the evening.21,22

Behavioural techniques

Sleep hygiene education

Sleep continuity can be enhanced by making small changes like keeping a cool, dark sleeping environment and avoiding coffee or large meals just before bed. Setting regular bedtimes strengthens circadian rhythms while limiting beverages in the evening lessens nightly awakenings.23

Cognitive behavioural therapy for insomnia

The best non-pharmacological treatment for insomnia is cognitive behavioural therapy (CBT-I). Research shows that people with liver cancer have a decreased wake-after-sleep onset and a delay in sleep onset. Using CBT-I increases the overall sleep duration and sleep efficiency by 10.6%. Restructuring negative sleep-related beliefs and establishing regular sleep routines are two strategies.24,25

Supportive care

Counselling and support groups

Insomnia is exacerbated by anxiety and depression, which are common in individuals with liver cancer. Psychological anguish is addressed by counselling, while coping mechanisms and peer validation are offered by support groups. For instance, encouraging shared experiences through support groups helps people feel less alone.26

Relaxation techniques

Mindfulness, progressive muscle relaxation, and guided visualisation all help to reduce sleep disturbances brought on by stress. Although melatonin metabolism can be altered by liver impairment, chamomile tea or melatonin supplements (under medical supervision) may also promote calm.2

Current research and future directions

Investigations into how sleep disturbances impact disease progression, treatment effectiveness, and the overall quality of life for patients with liver cancer are ongoing, highlighting the crucial role of sleep in managing this condition. Liver disorders alter the metabolism of melatonin, leading to disruptions in sleep-wake cycles that aggravate insomnia and daytime fatigue, as indicated by studies on circadian rhythm disturbances. 

Research is being conducted on chronotherapy for its potential to enhance treatment effectiveness and minimise side effects by aligning immunotherapy and chemotherapy with circadian rhythms.2,10,27,28

Both biological and psychological causes of sleep disruptions are being successfully addressed by customised sleep care programs, such as cognitive behavioural therapy for insomnia (CBT-I), customised nursing treatments, and integrative techniques like melatonin supplementation.28,29

The creation of biomarkers to steer customised treatment regimens, the use of wearable technology to track sleep patterns in real-time, and the promotion of regular sleep evaluations in oncology clinics are some future directions. By increasing survival rates and general quality of life, incorporating sleep management into liver cancer treatment has the potential to revolutionise patient outcomes.2,30

Summary

Liver cancer, primarily hepatocellular carcinoma (HCC), is a severe disease often seen in individuals with liver problems like cirrhosis or hepatitis. Early symptoms are usually unnoticed, but as the disease progresses, symptoms may include jaundice, abdominal pain, nausea, and fatigue. Treatment options vary based on cancer severity and include surgery, chemotherapy, targeted therapies, and radiation. Sleep plays a crucial role in overall health and liver function. Poor sleep quality increases the risk of liver problems by worsening factors like inflammation and insulin resistance. Managing sleep can mitigate these risks and improve cancer outcomes. Patients with liver cancer often face sleep issues, such as insomnia and excessive daytime sleepiness, which can worsen their condition and decrease their quality of life. Sleep disturbances may arise from the cancer diagnosis, treatment side effects, and pain.

Chronic liver disease can disrupt circadian rhythms, leading to further sleep problems. Additionally, insufficient sleep can impair treatment effectiveness due to hormonal imbalances essential for immune function. To manage sleep issues in liver cancer patients, effective strategies include pain management, medication timing adjustments aligned with biological rhythms, and cognitive behavioural therapy for insomnia. Relaxation techniques and mindfulness may also help. Future aims involve personalised treatments and tracking sleep patterns to enhance cancer care and improve overall patient well-being.

References

  1. Kalra A, Tuma F, Yetiskul E, Wehrle CJ. Physiology, Liver [Internet]. National Library of Medicine. StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535438/
  2. Shah NM, Malhotra AM, Kaltsakas G. Sleep disorder in patients with chronic liver disease: a narrative review. Journal of Thoracic Disease [Internet]. 2020 Oct 1;12(S2). Available from: https://jtd.amegroups.com/article/view/44498/html#:~:text=Abstract%3A%20Sleep%20disturbance%20is%20a
  3. Kim TW, Jeong JH, Hong SC. The Impact of Sleep and Circadian Disturbance on Hormones and Metabolism. International Journal of Endocrinology [Internet]. 2015 Mar 11;2015(591729):1–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377487/
  4. Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Advances in Cancer Research [Internet]. 2021;149:1–61. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8796122/
  5. Garikipati SC, Roy P. Biliary Tract Cholangiocarcinoma [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560708/
  6. Gosalia AJ, Martin P, Jones PD. Advances and Future Directions in the Treatment of Hepatocellular Carcinoma. Gastroenterology & Hepatology [Internet]. 2017 Jul;13(7):398. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5572970/
  7. Ferrante ND, Pillai A, Singal AG. Update on the Diagnosis and Treatment of Hepatocellular Carcinoma. Gastroenterology & Hepatology [Internet]. 2020 Oct;16(10):506. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8132669/
  8. Chen H, Zhou H, Wu B, Lu H, Zhang J, Zhang Y, et al. Physical activity and exercise in liver cancer. Liver research [Internet]. 2024 Mar 1;8(1):22–33. Available from: https://www.sciencedirect.com/science/article/pii/S2542568424000059
  9. Song J, Fan L, Shi D, Lai X, Wang H, Liu W, et al. Sleep and liver function biomarkers in relation to risk of incident liver cancer: a nationwide prospective cohort study. BMC Medicine [Internet]. 2024 Jun 24 [cited 2025 Apr 7];22(1). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11197319/
  10. Lanza G, Mogavero MP, Salemi M, Ferri R. The Triad of Sleep, Immunity, and Cancer: A Mediating Perspective. Cells [Internet]. 2024 Jul 24;13(15):1246–6. Available from: https://www.mdpi.com/2073-4409/13/15/1246
  11. Plotogea OM, Ilie M, Bungau S, Chiotoroiu AL, Stanescu AMA, Diaconu CC. Comprehensive Overview of Sleep Disorders in Patients with Chronic Liver Disease. Brain Sciences [Internet]. 2021 Jan 22 [cited 2022 Nov 28];11(2):142. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7911845/
  12. ANCOLI-ISRAEL S, MOORE PJ, JONES V. The relationship between fatigue and sleep in cancer patients: a review. European Journal of Cancer Care [Internet]. 2001 Dec [cited 2020 Oct 29];10(4):245–55. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC2951731/
  13. Bogan RK. Effects of restless legs syndrome (RLS) on sleep. Neuropsychiatric Disease and Treatment [Internet]. 2006 Dec [cited 2020 Mar 11];2(4):513–9. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC2671944/
  14. Sato K, Meng F, Francis H, Wu N, Chen L, Kennedy L, et al. Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies. Journal of Pineal Research [Internet]. 2020 Apr;68(3). Available from: https://pubmed.ncbi.nlm.nih.gov/32061110/
  15. Shi D, Chen J, Wang J, Yao J, Huang Y, Zhang G, et al. Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease. Frontiers in Physiology [Internet]. 2019 May 8;10. Available from: https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2019.00423/full
  16. Wang ZG, Wang Y, Huang J, Xu J, Chen F, Zhu Z, et al. Sleep Disturbance Affects Immune Factors in Clinical Liver Cancer Patients. 2022 Oct 20 [cited 2023 Jun 18];29(10):7943–52. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9600048/
  17. Montaruli A, Castelli L, Mulè A, Scurati R, Esposito F, Galasso L, et al. Biological Rhythm and Chronotype: New Perspectives in Health. Biomolecules [Internet]. 2021 Mar 24;11(4):487. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063933/
  18. Zhou L, Zhang Z, Nice E, Huang C, Zhang W, Tang Y. Circadian Rhythms and cancers: the Intrinsic Links and Therapeutic Potentials. Journal of Hematology & Oncology [Internet]. 2022 Mar 4;15(1). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8896306/
  19. Dorsey A, de Lecea L, Jennings KJ. Neurobiological and Hormonal Mechanisms Regulating Women’s Sleep. Frontiers in Neuroscience [Internet]. 2021 Jan 14;14. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7840832/
  20. Die Trill M. Anxiety and sleep disorders in cancer patients. European Journal of Cancer Supplements [Internet]. 2013 Sep;11(2):216–24. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4041166/
  21. Kumar M, Panda D. Role of Supportive Care for Terminal Stage Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology [Internet]. 2014 Aug;4(3):S130–9. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4284220/
  22. Amiama-Roig A, Verdugo-Sivianes EM, Carnero A, José Lopez Blanco. Chronotherapy: Circadian Rhythms and Their Influence in Cancer Therapy. Cancers [Internet]. 2022 Oct 17;14(20):5071–1. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599830/
  23. Lee Y, Field JM, Sehgal A. Circadian Rhythms, Disease and Chronotherapy. Journal of Biological Rhythms [Internet]. 2021 Sep 22;36(6):503–31. Available from: https://journals.sagepub.com/doi/full/10.1177/07487304211044301
  24. Foster RG. Sleep, Circadian Rhythms and Health. Interface Focus [Internet]. 2020 Apr 17;10(3):20190098. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7202392/
  25. Gao Y, Liu M, Yao L, Yang Z, Chen Y, Niu M, et al. Cognitive behavior therapy for insomnia in cancer patients: a systematic review and network meta-analysis. Journal of Evidence-Based Medicine [Internet]. 2022 Sep 1;15(3):216–29. Available from: https://pubmed.ncbi.nlm.nih.gov/35996803/#:~:text=Conclusions%3A%20CBT%2DI%20is%20effective
  26. Eva Rames Nissen, Neumann H, Sofie Møgelberg Knutzen, Emilie Nørholm Henriksen, Amidi A, Johansen C, et al. Interventions for insomnia in cancer patients and survivors—a comprehensive systematic review and meta-analysis. JNCI Cancer Spectrum [Internet]. 2024 Apr 30 [cited 2024 Aug 8];8(3). Available from: https://academic.oup.com/jncics/article/8/3/pkae041/7680549
  27. Grassi L, R. Zachariae, Caruso R, L. Palagini, R. Campos-Ródenas, Riba MB, et al. Insomnia in adult patients with cancer: ESMO Clinical Practice Guideline. ESMO Open [Internet]. 2023 Dec 1;8(6):102047–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774975/
  28. El-Tanani M, Rabbani SA, Ali AA, Alfaouri IGA, Al Nsairat H, Al-Ani IH, et al. Circadian rhythms and cancer: implications for timing in therapy. Discover Oncology [Internet]. 2024 Dec 18;15(1). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11655929/
  29. Edinger JD, Arnedt JT, Bertisch SM, Carney CE, Harrington JJ, Lichstein KL, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine [Internet]. 2021 Feb;17(2):255–62. Available from: https://jcsm.aasm.org/doi/10.5664/jcsm.8986
  30. Depner CM, Cheng PC, Devine JK, Khosla S, de Zambotti M, Robillard R, et al. Wearable technologies for developing sleep and circadian biomarkers: a summary of workshop discussions. Sleep [Internet]. 2019 Oct 23 [cited 2021 Nov 20];43(2). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7368340/

my.klarity.health presents all health information in line with our terms and conditions. It is essential to understand that the medical information available on our platform is not intended to substitute the relationship between a patient and their physician or doctor, as well as any medical guidance they offer. Always consult with a healthcare professional before making any decisions based on the information found on our website.
Klarity is a citizen-centric health data management platform that enables citizens to securely access, control and share their own health data. Klarity Health Library aims to provide clear and evidence-based health and wellness related informative articles. 
Email:
Klarity / Managed Self Ltd
Alum House
5 Alum Chine Road
Westbourne Bournemouth BH4 8DT
VAT Number: 362 5758 74
Company Number: 10696687

Phone Number:

 +44 20 3239 9818
my.klarity.health presents all health information in line with our terms and conditions. It is essential to understand that the medical information available on our platform is not intended to substitute the relationship between a patient and their physician or doctor, as well as any medical guidance they offer. Always consult with a healthcare professional before making any decisions based on the information found on our website.
Klarity is a citizen-centric health data management platform that enables citizens to securely access, control and share their own health data. Klarity Health Library aims to provide clear and evidence-based health and wellness related informative articles. 
Email:
Klarity / Managed Self Ltd
Alum House
5 Alum Chine Road
Westbourne Bournemouth BH4 8DT
VAT Number: 362 5758 74
Company Number: 10696687

Phone Number:

 +44 20 3239 9818
arrow-right